Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC-Reference-Cited by-同舟云学术

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC

Published:2016-10 Issue:10 Volume:11 Page:1729-1735
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Morgensztern Daniel,Du Lingling,Waqar Saiama N.,Patel Aalok,Samson Pamela,Devarakonda Siddhartha,Gao Feng,Robinson Cliff G.,Bradley Jeffrey,Baggstrom Maria,Masood Ashiq,Govindan Ramaswamy,Puri Varun

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington;Chest,2013

2. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

3. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

4. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

5. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesoporous silica nanoparticles: a versatile carrier platform in lung cancer management;Nanomedicine;2024-05-20

2. genRCT: a statistical analysis framework for generalizing RCT findings to real-world population;Journal of Biopharmaceutical Statistics;2024-04-08

3. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection;Neoplasia;2024-04

4. The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study;Journal of Thoracic Disease;2024-03

5. Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion;Frontiers in Oncology;2024-01-15